This platform uses AI to source sustainable and next-generation materials for buyers and suppliers. It collates fragmented market data and digitizes it to facilitate efficient sourcing, leading to cost savings and increased success rates for transactions. Global brands utilize this tool to streamline procurement across plastics, metals, glass, and other material categories.
Funding
$15.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Sourcing recycled plastics is challenging due to fragmented markets, opaque pricing, and difficulty accessing reliable technical data on post-consumer resin (PCR). This lack of transparency hinders brands from achieving sustainability goals and optimizing costs when transitioning from virgin plastics.
Solution
Circular.co offers a data-driven platform that connects buyers with a network of recycled plastic suppliers, streamlining the sourcing process through digital quotes and transparent pricing. The platform provides access to an extensive database of PCR technical data, enabling informed material selection and performance prediction. By digitizing the sourcing workflow, Circular.co simplifies supplier vetting, contract negotiation, logistics, and emissions measurement, empowering brands to achieve sustainability targets while reducing costs.
Target Audience
The primary target audience includes brands and manufacturers seeking to source recycled plastics at scale to meet sustainability goals and reduce costs.
Features
- Digital marketplace connecting buyers with over 9,000 global recycled plastic suppliers
- Custom digital quotes and transparent pricing for PCR materials
- Extensive database of over 50,000 PCR technical data records
- Tools for supplier vetting, onboarding, and contract management
- Integrated logistics support for efficient material transportation
- Emissions measurement tools to track and reduce environmental impact
- Average cost savings of 12% compared to PCR index pricing